WuXi PharmaTech (Cayman) Inc., an open-access R&D capability and technology platform company with operations in China and the U.S., has established a representative office in the Tel Aviv area of Israel.    The new office will promote WuXi’s platform of R&D services to local customers, and will also collaborate with Pontifax, a healthcare-dedicated venture capital firm based in Israel, to invest in promising local technologies that can potentially advance WuXi’s capabilities....